InnoCare Optoelectronics (6861) Q2 2025 earnings summary

Executive summary

• Revenue for the first half of 2024 reached NT$1,087,584 thousand, up 12% year-over-year from NT$968,238 thousand.

• Net income for the first half of 2024 was NT$74,905 thousand, a slight decrease from NT$81,385 thousand in the same period last year.

• Gross margin for the first half of 2024 was 28%, consistent with the prior year.

Financial highlights

• Operating income for the first half of 2024 was NT$81,583 thousand, down from NT$105,122 thousand year-over-year.

• Basic EPS for the first half of 2024 was NT$1.80, compared to NT$2.02 in the prior year.

• Cash and cash equivalents as of June 30, 2024, totaled NT$844,037 thousand, up from NT$631,448 thousand a year earlier.

• Total assets as of June 30, 2024, were NT$2,398,338 thousand.

Outlook and guidance

• The company continues to focus on X-ray flat panel detector medical business as its core segment.

• No significant changes in accounting policies or major impacts from new IFRS standards are expected in the near term.